Author

Antonio Martocchia

Sapienza University of Rome - S.Andrea Hospital - Cited by 1,103

Biography

Dr. Antonio Martocchia has earned his Degree in Medicine and Surgery (1992) from Sapienza University of Rome and done his specialization in Internal Medicine (1998) also from Sapienza University of Rome. He has a PhD in Neuroscience (2003) from the University of Brescia. Currently he is a Medical Director from S. Andrea Hospital Rome. He also holds the position of Professor in Internal Medicine, Master of Science in Nursing and in Geriatrics, Degree in Medicine, Sapienza University of Rome. 
Title
Cited by
Year
Prevalence of peripheral artery disease by abnormal ankle-brachial index in atrial fibrillation: implications for risk and therapy
F Violi, G Daví, W Hiatt, GYH Lip, GR Corazza, F Perticone, M Proietti, ...Journal of the American College of Cardiology (23), 2255-2256, 2013201
62
2013
Diagnosis of hepatic glycogenosis in poorly controlled type 1 diabetes mellitus
S Giordano, A Martocchia, L Toussan, M Stefanelli, F Pastore, A Devito, ...World journal of diabetes 5 (6), 882, 2014201
52
2014
Hepatitis C virus infection and thyroid autoimmune disorders: a model of interactions between the host and the environment
F Pastore, A Martocchia, M Stefanelli, P Prunas, S Giordano, L Toussan, ...World Journal of Hepatology 8 (2), 83, 2016201
45
2016
Relationship between carotid intima-media thickness and non valvular atrial fibrillation type
M Proietti, C Calvieri, L Malatino, S Signorelli, GR Corazza, F Perticone, ...Atherosclerosis 238 (2), 350-355, 2015201
42
2015
Frequency of left ventricular hypertrophy in non-valvular atrial fibrillation
M Proietti, AM Marra, EJ Tassone, S De Vuono, S Corrao, P Gobbi, ...The American Journal of Cardiology 116 (6), 877-882, 2015201
41
2015
Recent advances in the role of cortisol and metabolic syndrome in age-related degenerative diseases
A Martocchia, M Stefanelli, GM Falaschi, L Toussan, C Ferri, P FalaschiAging clinical and experimental research 28, 17-23, 2016201
41
2016
Clinical management of adult coronavirus infection disease 2019 (COVID-19) positive in the setting of low and medium intensity of care: a short practical review
A Pennica, G Conforti, F Falangone, A Martocchia, L Tafaro, ...SN Comprehensive Clinical Medicine 2 (6), 694-699, 2020202
40
2020
Ankle-Brachial Index and cardiovascular events in atrial fibrillation
F Violi, G Davi, M Proietti, D Pastori, WR Hiatt, GR Corazza, F Perticone, ...Thrombosis and Haemostasis 115 (04), 856-863, 2016201
39
2016
Sex steroids in autoimmune diseases
A Martocchia, M Stefanelli, S Cola, P FalaschiCurrent Topics in Medicinal Chemistry 11 (13), 1668-1683, 2011201
37
2011
Effects of escitalopram on serum BDNF levels in elderly patients with depression: a preliminary report
A Martocchia, M Curto, S Scaccianoce, F Comite, D Xenos, C Nasca, ...Aging Clinical and Experimental Research 26, 461-464, 2014201
33
2014
The prevention and treatment of delirium in elderly patients following hip fracture surgery
A Martocchia, M Curto, F Comite, S Scaccianoce, P Girardi, S Ferracuti, ...Recent Patents on CNS Drug Discovery (Discontinued) 10 (1), 55-64, 2015201
31
2015
Carotid plaque detection improves the predictive value of CHA2DS2-VASc score in patients with non-valvular atrial fibrillation: The ARAPACIS Study
S Basili, L Loffredo, D Pastori, M Proietti, A Farcomeni, AR Vestri, ...International journal of cardiology 1, 143-149, 2017201
23
2017
Increased total urinary cortisol (tUC) and serum brain-derived neurotrophic factor (BDNF) ratio in Alzheimer disease (AD)-affected patients
M Curto, A Martocchia, S Ferracuti, F Comite, S Scaccianoce, P Girardi, ...Alzheimer Disease & Associated Disorders 31 (2), 173-176, 2017201
21
2017
Pharmacological strategies against glucocorticoid-mediated brain damage during chronic disorders
A Martocchia, M Curto, L Toussan, M Stefanelli, P FalaschiRecent Patents on CNS Drug Discovery (Discontinued) 6 (3), 196-204, 2011201
18
2011
Screening of frailty in elderly patients with disability by the means of Marigliano–Cacciafesta polypathology scale (MCPS) and Canadian Study of Health and Aging (CSHA) scales
A Martocchia, P Frugoni, I Indiano, L Tafaro, F Comite, A Amici, ...Archives of gerontology and geriatrics 56 (2), 339-342, 2013201
16
2013
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study
V Raparelli, D Pastori, SF Pignataro, AR Vestri, P Pignatelli, R Cangemi, ...Internal and emergency medicine 13, 651-660, 2018201
14
2018
Targets of anti-glucocorticoid therapy for stress-related diseases.
A Martocchia, M Stefanelli, GM Falaschi, L Toussan, S Raja, G Romano, ...Recent patents on CNS drug discovery 8 (1), 79-87, 2013201
12
2013
Using INTERCheck® to Evaluate the Incidence of Adverse Events and Drug–Drug Interactions in Out- and Inpatients Exposed to Polypharmacy
A Martocchia, V Spuntarelli, F Aiello, AL Meccariello, M Proietta, ...Drugs-Real World Outcomes 7, 243-249, 2020202
10
2020
The cortisol burden in elderly subjects with metabolic syndrome and its association with low-grade inflammation
A Martocchia, M Gallucci, M Noale, S Maggi, M Cassol, M Stefanelli, ...Aging Clinical and Experimental Research 32, 1309-1315, 2020202
7
2020
Treatment of insulin resistance in the neurodegeneration
M Stefanelli, A Martocchia, E Adele De Marinis, G Maria Falaschi, ...Recent Patents on CNS Drug Discovery (Discontinued) 9 (1), 54-63, 2014201
7
2014